A nurse in a health clinic is assisting in the care of a client diagnosed with chlamydia. The client was prescribed azithromycin 1 g PO once. Which of the following allergy findings in the client's history should the nurse report to the provider?

Choice A reason: Family history informs genetic risks, not current mobility needs for therapy. Scientifically, it’s less relevant than functional data, as physical therapy focuses on present deficits, not hereditary patterns, making this secondary for referral purposes.

Choice B reason: Prior medications provide context but don’t detail current physical status for therapy goals. Scientifically, recent assessments outweigh past drug use, as therapists need functional baselines, not historical pharmacology, for effective planning.

Choice C reason: Physical assessment findings (e.g., strength, range of motion) directly inform therapy needs, setting baselines for intervention. Scientifically, this data drives rehabilitation plans, aligning with evidence-based practice to target specific deficits for mobility recovery.

Choice D reason: Insurance claims are administrative, not clinical, data. They don’t guide therapy goals or interventions. Scientifically, financial details are irrelevant to physical assessment, making this inappropriate for a referral focused on functional restoration.

Choice A reason: Exchange transfusion treats severe conditions like hyperbilirubinemia, not HIV. It’s irrelevant for a 10-month-old’s ongoing viral management needs.

Choice B reason: Granulocyte colony-stimulating factor boosts neutrophils, not lymphocytes, in neutropenia. HIV targets CD4 cells, making this an ineffective intervention here.

Choice C reason: Droplet precautions suit respiratory infections, not HIV, which spreads via blood/body fluids. Standard precautions suffice, so this isn’t needed.

Choice D reason: Monitoring lymphocyte (CD4) count tracks HIV progression in infants. It guides antiretroviral therapy, a critical ongoing management step at 10 months.